Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKenet, Gili
dc.contributor.authorNolan, Beatrice
dc.contributor.authorFikar, Bulent Zul
dc.contributor.authorAntmen, Bulent
dc.contributor.authorKampmann, Peter
dc.contributor.authorMatsushita, Tadashi
dc.contributor.authorYou, Chur\\-Woo
dc.contributor.authorVilchevska, Kateryna
dc.contributor.authorBagot, Catherine N.
dc.contributor.authorSharif, Azizan
dc.contributor.authorPeyvandi, Flora
dc.contributor.authorYoung, Guy
dc.contributor.authorNegrier, Claude
dc.contributor.authorChi, Jiarui
dc.contributor.authorKittner, Barbara
dc.contributor.authorSussebach, Christian
dc.contributor.authorShammas, Fadi
dc.contributor.authorMei, Baisong
dc.contributor.authorAndersson, Shauna
dc.contributor.authorKavakli, Kaan
dc.date.accessioned2025-10-16T15:13:20Z
dc.date.issued2024
dc.identifier.doi10.1182/blood.2023021864
dc.identifier.otherWOS:001248293900001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5773
dc.publisherELSEVIER
dc.sourceBLOOD
dc.titleFitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS